Gilead Sciences has entered a strategic partnership with Terray Therapeutics for the discovery and development of small-molecule therapies across several targets. The partnership leverages Terray ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...

Gilead (GILD) and Terray Therapeutics announced that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets.

BigHat Biosciences, Terray Therapeutics and AWS discuss topics including company building, science fact vs. fiction and the future of medicine. Understand how the intersection of biology and ...

The United States market has experienced a notable upswing, climbing by 3.8% over the past week and achieving a 24% increase over the last year, with earnings forecasted to grow by 15% annually. In ...

To empower researchers to explore the chemical space composed of over 10^60 – or novemdecillion – possible drug-like molecules, Terray Therapeutics is harnessing the power of accelerated ...

Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- -- Gilead Has Exclusive Option to Develop and ...